SciSparc (SPRC) Current Assets (2016 - 2025)
SciSparc (SPRC) posted Current Assets of $5.4 million for Q4 2025, up 97.74% sequentially from $2.7 million in Q2 2025, and down 27.55% YoY from $7.5 million in Q4 2024.
SciSparc (SPRC) Current Assets (2016 - 2025) Analysis & Trends
SciSparc has reported Current Assets for 10 years, with the latest figure at $5.4 million in Q4 2025.
- Quarterly Current Assets fell 27.55% year-over-year to $5.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.4 million (down 27.55% YoY) and the FY2025 annual result came in at $5.4 million, down 27.55% from the prior year.
- Current Assets advanced to $5.4 million in Q4 2025 per SPRC's latest filing, from $2.7 million in the prior quarter.
- Over five years, Current Assets peaked at $13.7 million in Q2 2022 and troughed at $2.7 million in Q2 2025.
- A 5-year average of $6.5 million and a median of $5.9 million in 2023 frame the typical range for Current Assets.
- The sharpest annual moves came in 2021 and 2023: Current Assets jumped 928.64% in 2021, then tumbled 73.38% in 2023.
- Over 5 years, Current Assets stood at $9.8 million in 2021, then sank by 54.09% to $4.5 million in 2022, then jumped by 42.9% to $6.4 million in 2023, then climbed by 16.42% to $7.5 million in 2024, then decreased by 27.55% to $5.4 million in 2025.
- According to Business Quant data, Current Assets over the past three periods registered $5.4 million, $2.7 million, and $7.5 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 4.62 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.63 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.76 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 18.80 Bn |
| 10 | SciSparc | 836,385.99 | 836,385.99 | - | 5.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.44 Mn |
| Jun 30, 2025 | 2.75 Mn |
| Dec 31, 2024 | 7.50 Mn |
| Jun 30, 2024 | 3.36 Mn |
| Dec 31, 2023 | 6.45 Mn |
| Jun 30, 2023 | 3.64 Mn |
| Dec 31, 2022 | 4.51 Mn |
| Jun 30, 2022 | 13.68 Mn |
| Dec 31, 2021 | 9.82 Mn |
| Jun 30, 2021 | 8.33 Mn |
| Dec 31, 2020 | 2.55 Mn |
| Jun 30, 2020 | 810,000.00 |
| Dec 31, 2019 | 955,000.00 |
| Jun 30, 2019 | 1.85 Mn |
| Dec 31, 2018 | 2.43 Mn |
| Jun 30, 2018 | 6.28 Mn |
| Dec 31, 2017 | 9.50 Mn |
| Sep 30, 2017 | 10.96 Mn |
| Jun 30, 2017 | 12.04 Mn |
| Mar 31, 2017 | 12.20 Mn |